Generation Bio Co. (GBIO) NASDAQ
$2.99 (0.27) (-8.28%)
Market Cap: $216.72M
As of 04/24/24 04:00 PM EDT. Market closed.
Generation Bio Co. (GBIO)
NASDAQ
$2.99
(0.27) (-8.28%)
Market Cap: $216.72M
As of 04/24/24 04:00 PM EDT. Market closed.
generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the ... read more
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 15, 2024 | Option Exercise | $3.70 | 492 | 1,820 | 244,955 | Apr 17, 2024, 05:10 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Apr 15, 2024 | Option Exercise | $3.70 | 337 | 1,247 | 113,758 | Apr 17, 2024, 05:10 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Apr 15, 2024 | Option Exercise | $3.70 | 468 | 1,732 | 13,807 | Apr 17, 2024, 05:10 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Apr 15, 2024 | Option Exercise | $3.70 | 984 | 3,641 | 52,622 | Apr 17, 2024, 05:10 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Apr 15, 2024 | Option Exercise | $3.70 | 1,548 | 5,728 | 1,323,458 | Apr 17, 2024, 05:10 PM |
Howze Yalonda | CHIEF LEGAL OFFICER | Apr 15, 2024 | Option Exercise | $3.70 | 3,930 | 14,541 | 9,458 | Apr 17, 2024, 05:10 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 29, 2024 | Option Exercise | $1.90 | 1,476 | 2,804 | 49,164 | Jan 31, 2024, 04:30 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 29, 2024 | Option Exercise | $1.90 | 1,476 | 2,804 | 385,628 | Jan 31, 2024, 04:30 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 45,619 | Jan 17, 2024, 05:00 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 382,083 | Jan 17, 2024, 05:00 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 4,897 | 9,353 | 243,773 | Jan 17, 2024, 05:00 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 5,478 | 10,463 | 50,259 | Jan 17, 2024, 05:00 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jan 15, 2024 | Option Exercise | $1.91 | 15,431 | 29,473 | 1,319,732 | Jan 17, 2024, 05:00 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 3,020 | 5,768 | 112,948 | Jan 17, 2024, 05:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 15, 2024 | Option Exercise | $1.91 | 3,637 | 6,947 | 12,683 | Jan 17, 2024, 05:00 PM |
Appelhans Dannielle | Director | Dec 08, 2023 | Buy | $1.79 | 7,363 | 13,180 | 7,363 | Dec 11, 2023, 04:30 PM |
Appelhans Dannielle | Director | Dec 08, 2023 | Buy | $1.82 | 637 | 1,159 | 12,637 | Dec 11, 2023, 04:30 PM |
Appelhans Dannielle | Director | Dec 04, 2023 | Buy | $1.50 | 12,000 | 18,000 | 12,000 | Dec 06, 2023, 04:30 PM |
Quinn Anthony G. | Director | Dec 01, 2023 | Buy | $1.41 | 88,495 | 124,778 | 88,495 | Dec 05, 2023, 04:30 PM |
Rowland Charles A Jr | Director | Dec 04, 2023 | Buy | $1.50 | 150,000 | 225,000 | 534,757 | Dec 05, 2023, 04:30 PM |
Rowland Charles A Jr | Director | Dec 01, 2023 | Buy | $1.31 | 192,960 | 252,778 | 384,757 | Dec 05, 2023, 04:30 PM |
Nicholson Donald William | Director | Dec 01, 2023 | Buy | $1.44 | 100,000 | 144,000 | 213,576 | Dec 05, 2023, 04:30 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 1,211 | 3,924 | 107,256 | Oct 17, 2023, 06:00 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 234,539 | Oct 17, 2023, 06:00 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 36,385 | Oct 17, 2023, 06:00 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,675 | 8,667 | 39,932 | Oct 17, 2023, 06:00 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Oct 15, 2023 | Option Exercise | $3.24 | 10,395 | 33,680 | 1,288,187 | Oct 17, 2023, 06:00 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 2,183 | 7,073 | 370,404 | Oct 17, 2023, 06:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 15, 2023 | Option Exercise | $3.24 | 1,211 | 3,924 | 5,828 | Oct 17, 2023, 06:00 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Aug 23, 2023 | Sale | $4.93 | 3,116 | 15,362 | 2,914 | Aug 25, 2023, 04:35 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 1,211 | 6,152 | 104,342 | Jul 18, 2023, 04:35 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 229,285 | Jul 18, 2023, 04:35 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 1,211 | 6,152 | 6,030 | Jul 18, 2023, 04:35 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 31,131 | Jul 18, 2023, 04:35 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 3,166 | 16,083 | 33,496 | Jul 18, 2023, 04:35 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jul 15, 2023 | Option Exercise | $5.08 | 7,476 | 37,978 | 1,275,145 | Jul 18, 2023, 04:35 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 15, 2023 | Option Exercise | $5.08 | 2,183 | 11,090 | 365,150 | Jul 18, 2023, 04:35 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Apr 25, 2023 | Sale | $4.61 | 2,914 | 13,434 | 0 | Apr 26, 2023, 04:16 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 1,211 | 5,450 | 101,428 | Apr 18, 2023, 04:24 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 224,031 | Apr 18, 2023, 04:22 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 1,211 | 5,450 | 2,914 | Apr 18, 2023, 04:21 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 25,877 | Apr 18, 2023, 04:19 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 25,877 | Apr 18, 2023, 04:17 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Apr 15, 2023 | Option Exercise | $4.50 | 6,879 | 30,956 | 1,256,068 | Apr 18, 2023, 04:16 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Apr 15, 2023 | Option Exercise | $4.50 | 2,183 | 9,824 | 356,780 | Apr 18, 2023, 04:14 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 26, 2023 | Sale | $5.56 | 2,695 | 14,984 | 0 | Jan 27, 2023, 04:22 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 20,623 | Jan 18, 2023, 05:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 218,777 | Jan 18, 2023, 05:02 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 1,430 | 7,293 | 98,514 | Jan 18, 2023, 04:59 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 20,623 | Jan 18, 2023, 04:57 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jan 15, 2023 | Option Exercise | $5.10 | 8,122 | 41,422 | 1,239,510 | Jan 18, 2023, 04:54 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 2,578 | 13,148 | 351,526 | Jan 18, 2023, 04:52 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 15, 2023 | Option Exercise | $5.10 | 1,430 | 7,293 | 2,695 | Jan 18, 2023, 04:50 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jan 10, 2023 | Sale | $4.57 | 1,865 | 8,523 | 0 | Jan 11, 2023, 04:25 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Jan 09, 2023 | Sale | $5.11 | 1,865 | 9,530 | 95,819 | Jan 10, 2023, 04:57 PM |
Cooper Ronald Harold Wilfred | Director | Jan 05, 2023 | Option Exercise | $5.12 | 9,500 | 48,640 | 9,500 | Jan 09, 2023, 05:23 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 27, 2022 | Sale | $5.03 | 2,914 | 14,657 | 0 | Oct 28, 2022, 04:05 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 1,211 | 6,794 | 2,914 | Oct 18, 2022, 04:46 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 15,763 | Oct 18, 2022, 04:45 PM |
Samayoa Phillip | CHIEF STRATEGY OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 1,211 | 6,794 | 95,819 | Oct 18, 2022, 04:44 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 213,917 | Oct 18, 2022, 04:43 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 344,801 | Oct 18, 2022, 04:41 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Oct 15, 2022 | Option Exercise | $5.61 | 2,184 | 12,252 | 15,763 | Oct 18, 2022, 04:40 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Oct 15, 2022 | Option Exercise | $5.61 | 10,395 | 58,316 | 1,222,329 | Oct 18, 2022, 04:38 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Sep 29, 2022 | Sale | $5.24 | 2,828 | 14,819 | 0 | Sep 30, 2022, 04:05 PM |
Rowland Charles A Jr | Director | Sep 19, 2022 | Buy | $5.26 | 15,750 | 82,845 | 191,797 | Sep 20, 2022, 04:16 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Sep 15, 2022 | Sale | $5.32 | 4,610 | 24,525 | 2,828 | Sep 19, 2022, 05:33 PM |
Rowland Charles A Jr | Director | Sep 16, 2022 | Buy | $5.48 | 33,481 | 183,476 | 176,047 | Sep 19, 2022, 05:21 PM |
Rowland Charles A Jr | Director | Sep 15, 2022 | Buy | $5.41 | 17,147 | 92,765 | 142,566 | Sep 19, 2022, 05:21 PM |
Rowland Charles A Jr | Director | Sep 14, 2022 | Buy | $5.30 | 5,600 | 29,652 | 125,419 | Sep 15, 2022, 04:07 PM |
Rowland Charles A Jr | Director | Sep 13, 2022 | Buy | $5.20 | 18,784 | 97,752 | 119,819 | Sep 15, 2022, 04:07 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Jul 15, 2022 | Option Exercise | $7.18 | 14,150 | 101,597 | 1,209,286 | Jul 19, 2022, 04:22 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 339,547 | Jul 19, 2022, 04:19 PM |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 10,509 | Jul 19, 2022, 04:16 PM |
Paone Antoinette | CHIEF OPERATING OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 2,422 | 17,390 | 7,438 | Jul 19, 2022, 04:14 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 208,663 | Jul 19, 2022, 04:11 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jul 15, 2022 | Option Exercise | $7.18 | 4,367 | 31,355 | 10,509 | Jul 19, 2022, 04:09 PM |
Nicholson Donald William | Director | Mar 09, 2022 | Buy | $4.79 | 2,293 | 10,983 | 105,450 | Mar 11, 2022, 04:53 PM |
Nicholson Donald William | Director | Mar 10, 2022 | Buy | $4.71 | 8,126 | 38,273 | 113,576 | Mar 11, 2022, 04:53 PM |
Rhodes Jason P | Director | Sep 29, 2021 | Sale | $24.59 | 16,586 | 407,850 | 608 | Sep 29, 2021, 07:16 PM |
Rhodes Jason P | Director | Sep 28, 2021 | Sale | $25.24 | 13,113 | 330,972 | 16,556 | Sep 29, 2021, 07:16 PM |
Rhodes Jason P | Director | Sep 27, 2021 | Sale | $25.70 | 51,389 | 1,320,697 | 29,645 | Sep 29, 2021, 07:16 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 28, 2021 | Sale | $25.24 | 24 | 606 | 638 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 28, 2021 | Sale | $25.24 | 13,089 | 330,366 | 16,556 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 27, 2021 | Sale | $25.70 | 95 | 2,442 | 662 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 27, 2021 | Sale | $25.70 | 51,294 | 1,318,256 | 29,645 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 29, 2021 | Sale | $24.59 | 30 | 738 | 608 | Sep 29, 2021, 07:15 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 29, 2021 | Sale | $24.59 | 16,556 | 407,112 | 0 | Sep 29, 2021, 07:15 PM |
Rhodes Jason P | Director | Sep 22, 2021 | Sale | $25.89 | 30,617 | 792,705 | 185,126 | Sep 24, 2021, 09:02 PM |
Rhodes Jason P | Director | Sep 24, 2021 | Sale | $25.84 | 28,916 | 747,161 | 80,939 | Sep 24, 2021, 09:02 PM |
Rhodes Jason P | Director | Sep 23, 2021 | Sale | $26.13 | 75,465 | 1,972,127 | 109,802 | Sep 24, 2021, 09:02 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 24, 2021 | Sale | $25.84 | 54 | 1,395 | 757 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 23, 2021 | Sale | $26.13 | 140 | 3,659 | 811 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 22, 2021 | Sale | $25.89 | 57 | 1,476 | 951 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 24, 2021 | Sale | $25.84 | 28,862 | 745,765 | 80,939 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 23, 2021 | Sale | $26.13 | 75,325 | 1,968,469 | 109,802 | Sep 24, 2021, 08:59 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sep 22, 2021 | Sale | $25.89 | 30,560 | 791,229 | 185,126 | Sep 24, 2021, 08:59 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 14, 2021 | Option Exercise | $4.59 | 4,500 | 20,655 | 202,654 | Sep 16, 2021, 04:12 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 14, 2021 | Sale | $28.07 | 4,500 | 126,315 | 198,154 | Sep 16, 2021, 04:12 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 10, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 201,154 | Sep 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Sep 10, 2021 | Sale | $25.97 | 3,000 | 77,910 | 198,954 | Sep 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 23, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | Aug 25, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 23, 2021 | Sale | $25.04 | 1,500 | 37,560 | 198,154 | Aug 25, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 10, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | Aug 11, 2021, 04:20 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Aug 10, 2021 | Sale | $22.63 | 1,500 | 33,943 | 198,654 | Aug 11, 2021, 04:20 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 12, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 201,154 | Jul 14, 2021, 04:02 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jul 12, 2021 | Sale | $25.03 | 3,000 | 75,087 | 199,854 | Jul 14, 2021, 04:02 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 08, 2021 | Option Exercise | $5.16 | 3,518 | 18,153 | 330,076 | Jul 12, 2021, 04:02 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jul 08, 2021 | Sale | $25.20 | 3,518 | 88,670 | 328,447 | Jul 12, 2021, 04:02 PM |
Rhodes Jason P | Director | Jun 24, 2021 | Sale | $25.85 | 31,008 | 801,618 | 4,092 | Jun 28, 2021, 04:57 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 24, 2021 | Sale | $25.85 | 30,950 | 800,119 | 4,092 | Jun 28, 2021, 04:56 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 24, 2021 | Sale | $25.86 | 58 | 1,500 | 616 | Jun 28, 2021, 04:56 PM |
Rhodes Jason P | Director | Jun 23, 2021 | Sale | $25.36 | 62,609 | 1,587,548 | 59,281 | Jun 23, 2021, 08:27 PM |
Rhodes Jason P | Director | Jun 22, 2021 | Sale | $24.95 | 58,577 | 1,461,479 | 118,651 | Jun 23, 2021, 08:27 PM |
Rhodes Jason P | Director | Jun 21, 2021 | Sale | $24.84 | 63,892 | 1,586,940 | 155,708 | Jun 23, 2021, 08:27 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 23, 2021 | Sale | $25.36 | 62,493 | 1,584,606 | 59,281 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 21, 2021 | Sale | $24.84 | 63,774 | 1,584,009 | 155,708 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 22, 2021 | Sale | $24.95 | 108 | 2,695 | 829 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 22, 2021 | Sale | $24.95 | 58,469 | 1,458,784 | 118,651 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 23, 2021 | Sale | $25.36 | 116 | 2,942 | 719 | Jun 23, 2021, 08:26 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Jun 21, 2021 | Sale | $24.84 | 118 | 2,931 | 897 | Jun 23, 2021, 08:26 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | May 27, 2021 | Option Exercise | $4.59 | 1,500 | 6,885 | 199,654 | May 28, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | May 27, 2021 | Sale | $34.05 | 1,500 | 51,075 | 198,154 | May 28, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 22, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Apr 23, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Apr 22, 2021 | Sale | $33.32 | 2,500 | 83,300 | 0 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 21, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 22, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 22, 2021 | Sale | $34.03 | 1,500 | 51,045 | 198,154 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 21, 2021 | Sale | $31.07 | 1,500 | 46,605 | 198,154 | Apr 23, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 16, 2021 | Option Exercise | $0.60 | 1,500 | 900 | 199,654 | Apr 20, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Apr 16, 2021 | Sale | $28.03 | 1,500 | 42,045 | 198,154 | Apr 20, 2021, 04:05 PM |
Rhodes Jason P | Director | Apr 14, 2021 | Sale | $26.61 | 23,413 | 622,995 | 12,874 | Apr 14, 2021, 08:20 PM |
Rhodes Jason P | Director | Apr 13, 2021 | Sale | $25.16 | 43,145 | 1,085,744 | 30,767 | Apr 14, 2021, 08:20 PM |
Rhodes Jason P | Director | Apr 12, 2021 | Sale | $26.15 | 74,124 | 1,938,229 | 77,329 | Apr 14, 2021, 08:20 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 13, 2021 | Sale | $25.16 | 43,145 | 1,085,744 | 30,767 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 12, 2021 | Sale | $26.15 | 74,124 | 1,938,229 | 77,329 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 14, 2021 | Sale | $26.61 | 23,413 | 622,995 | 12,874 | Apr 14, 2021, 08:19 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 09, 2021 | Sale | $27.61 | 43,681 | 1,205,948 | 142,814 | Apr 09, 2021, 08:54 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 08, 2021 | Sale | $28.50 | 43,550 | 1,241,241 | 187,554 | Apr 09, 2021, 08:54 PM |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Apr 07, 2021 | Sale | $28.51 | 39,864 | 1,136,671 | 229,807 | Apr 09, 2021, 08:54 PM |
Rhodes Jason P | Director | Apr 07, 2021 | Sale | $28.51 | 39,864 | 1,136,671 | 229,807 | Apr 09, 2021, 08:53 PM |
Rhodes Jason P | Director | Apr 09, 2021 | Sale | $27.61 | 43,681 | 1,205,948 | 142,814 | Apr 09, 2021, 08:53 PM |
Rhodes Jason P | Director | Apr 08, 2021 | Sale | $28.50 | 43,550 | 1,241,241 | 187,554 | Apr 09, 2021, 08:53 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Mar 10, 2021 | Option Exercise | $0.60 | 10,500 | 6,300 | 208,654 | Mar 12, 2021, 04:03 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Mar 10, 2021 | Sale | $34.97 | 10,500 | 367,209 | 204,104 | Mar 12, 2021, 04:03 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Mar 09, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Mar 05, 2021 | Sale | $31.44 | 11,267 | 354,267 | 335,148 | Mar 09, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 03, 2021 | Option Exercise | $4.59 | 3,000 | 13,770 | 3,000 | Mar 05, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 03, 2021 | Sale | $41.38 | 3,000 | 124,140 | 0 | Mar 05, 2021, 04:05 PM |
MCDONOUGH GEOFF | PRESIDENT AND CEO | Mar 01, 2021 | Sale | $37.58 | 10,000 | 375,801 | 1,202,690 | Mar 03, 2021, 04:10 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 01, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Mar 03, 2021, 04:10 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Mar 01, 2021 | Sale | $38.84 | 2,500 | 97,099 | 2,300 | Mar 03, 2021, 04:10 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Feb 10, 2021 | Option Exercise | $0.60 | 10,400 | 6,240 | 208,554 | Feb 12, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Feb 10, 2021 | Sale | $34.60 | 10,400 | 359,856 | 205,925 | Feb 12, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Feb 08, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Feb 10, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Feb 08, 2021 | Sale | $33.37 | 11,267 | 375,954 | 330,325 | Feb 10, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Feb 02, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Feb 04, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Feb 02, 2021 | Sale | $33.05 | 2,500 | 82,625 | 0 | Feb 04, 2021, 04:05 PM |
Angelino Mark D. | CHIEF OPERATING OFFICER | Jan 15, 2021 | Option Exercise | $4.59 | 7,500 | 34,425 | 353,137 | Jan 20, 2021, 04:05 PM |
Angelino Mark D. | CHIEF OPERATING OFFICER | Jan 15, 2021 | Sale | $32.97 | 7,500 | 247,273 | 349,637 | Jan 20, 2021, 04:05 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 14, 2021 | Option Exercise | $4.59 | 2,500 | 11,475 | 2,500 | Jan 15, 2021, 04:06 PM |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | Jan 14, 2021 | Sale | $33.09 | 2,500 | 82,725 | 0 | Jan 15, 2021, 04:06 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 14, 2021 | Option Exercise | $0.60 | 5,630 | 3,378 | 203,784 | Jan 15, 2021, 04:05 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 14, 2021 | Sale | $32.54 | 5,630 | 183,212 | 200,944 | Jan 15, 2021, 04:05 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 11, 2021 | Option Exercise | $4.59 | 11,267 | 51,716 | 337,825 | Jan 13, 2021, 04:07 PM |
Kerr Douglas | CHIEF MEDICAL OFFICER | Jan 11, 2021 | Sale | $27.58 | 11,267 | 310,768 | 331,579 | Jan 13, 2021, 04:07 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 11, 2021 | Option Exercise | $0.60 | 14,820 | 8,892 | 212,974 | Jan 13, 2021, 04:06 PM |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | Jan 11, 2021 | Sale | $27.69 | 14,820 | 410,372 | 206,705 | Jan 13, 2021, 04:06 PM |
Nicholson Donald William | Director | Jan 11, 2021 | Buy | $24.50 | 4,081 | 99,985 | 103,157 | Jan 13, 2021, 04:05 PM |
Rowland Charles A Jr | Director | Jan 11, 2021 | Buy | $24.50 | 20,408 | 499,996 | 101,035 | Jan 13, 2021, 04:04 PM |
Angelino Mark D. | Chief Operating Officer | Dec 15, 2020 | Option Exercise | $4.59 | 5,301 | 24,332 | 350,938 | Dec 17, 2020, 04:05 PM |
Angelino Mark D. | Chief Operating Officer | Dec 15, 2020 | Sale | $34.98 | 5,301 | 185,431 | 346,537 | Dec 17, 2020, 04:05 PM |
Stanton Matthew | Chief Scientific Officer | Dec 10, 2020 | Option Exercise | $0.60 | 10,540 | 6,324 | 208,694 | Dec 14, 2020, 04:05 PM |
Stanton Matthew | Chief Scientific Officer | Dec 10, 2020 | Sale | $37.62 | 10,540 | 396,499 | 203,376 | Dec 14, 2020, 04:05 PM |
Angelino Mark D. | Chief Operating Officer | Aug 14, 2020 | Option Exercise | $0.60 | 62,560 | 37,536 | 345,637 | Aug 18, 2020, 04:07 PM |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 1,100,000 | 20,900,000 | 2,112,546 | Jun 18, 2020, 06:02 PM |
Invus Public Equities, L.P. | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 800,000 | 15,200,000 | 2,814,191 | Jun 18, 2020, 06:01 PM |
Rowland Charles A Jr | Director | Jun 16, 2020 | Buy | $19.00 | 30,000 | 570,000 | 80,627 | Jun 18, 2020, 05:30 PM |
Casdin Capital, LLC | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 650,000 | 12,350,000 | 1,611,215 | Jun 18, 2020, 05:29 PM |
Zone Healthcare Holdings, LLC | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 1,918,819 | Jun 17, 2020, 05:00 PM |
Seybold William | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 1,918,819 | Jun 17, 2020, 04:59 PM |
Flynn James E | 10% Owner | Jun 16, 2020 | Buy | $19.00 | 225,000 | 4,275,000 | 1,186,215 | Jun 16, 2020, 02:50 PM |
Owner | Relationship | Date | Value($) |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/15/2024 | 1,820 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 04/15/2024 | 1,247 |
Paone Antoinette | CHIEF OPERATING OFFICER | 04/15/2024 | 1,732 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 04/15/2024 | 3,641 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 04/15/2024 | 5,728 |
Howze Yalonda | CHIEF LEGAL OFFICER | 04/15/2024 | 14,541 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/29/2024 | 2,804 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/29/2024 | 2,804 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/15/2024 | 9,353 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/15/2024 | 9,353 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/15/2024 | 9,353 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 01/15/2024 | 10,463 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 01/15/2024 | 29,473 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/15/2024 | 5,768 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/15/2024 | 6,947 |
Appelhans Dannielle | Director | 12/08/2023 | 13,180 |
Appelhans Dannielle | Director | 12/08/2023 | 1,159 |
Appelhans Dannielle | Director | 12/04/2023 | 18,000 |
Quinn Anthony G. | Director | 12/01/2023 | 124,778 |
Rowland Charles A Jr | Director | 12/04/2023 | 225,000 |
Rowland Charles A Jr | Director | 12/01/2023 | 252,778 |
Nicholson Donald William | Director | 12/01/2023 | 144,000 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 10/15/2023 | 3,924 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 10/15/2023 | 7,073 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 10/15/2023 | 7,073 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 10/15/2023 | 8,667 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 10/15/2023 | 33,680 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 10/15/2023 | 7,073 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/15/2023 | 3,924 |
Paone Antoinette | CHIEF OPERATING OFFICER | 08/23/2023 | 15,362 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 07/15/2023 | 6,152 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/15/2023 | 11,090 |
Paone Antoinette | CHIEF OPERATING OFFICER | 07/15/2023 | 6,152 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 07/15/2023 | 11,090 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 07/15/2023 | 16,083 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 07/15/2023 | 37,978 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/15/2023 | 11,090 |
Paone Antoinette | CHIEF OPERATING OFFICER | 04/25/2023 | 13,434 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 04/15/2023 | 5,450 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/15/2023 | 9,824 |
Paone Antoinette | CHIEF OPERATING OFFICER | 04/15/2023 | 5,450 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/15/2023 | 9,824 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 04/15/2023 | 9,824 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 04/15/2023 | 30,956 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 04/15/2023 | 9,824 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/26/2023 | 14,984 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/15/2023 | 13,148 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/15/2023 | 13,148 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/15/2023 | 7,293 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 01/15/2023 | 13,148 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 01/15/2023 | 41,422 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/15/2023 | 13,148 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/15/2023 | 7,293 |
Paone Antoinette | CHIEF OPERATING OFFICER | 01/10/2023 | 8,523 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 01/09/2023 | 9,530 |
Cooper Ronald Harold Wilfred | Director | 01/05/2023 | 48,640 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/27/2022 | 14,657 |
Paone Antoinette | CHIEF OPERATING OFFICER | 10/15/2022 | 6,794 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 10/15/2022 | 12,252 |
Samayoa Phillip | CHIEF STRATEGY OFFICER | 10/15/2022 | 6,794 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 10/15/2022 | 12,252 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 10/15/2022 | 12,252 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 10/15/2022 | 12,252 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 10/15/2022 | 58,316 |
Paone Antoinette | CHIEF OPERATING OFFICER | 09/29/2022 | 14,819 |
Rowland Charles A Jr | Director | 09/19/2022 | 82,845 |
Paone Antoinette | CHIEF OPERATING OFFICER | 09/15/2022 | 24,525 |
Rowland Charles A Jr | Director | 09/16/2022 | 183,476 |
Rowland Charles A Jr | Director | 09/15/2022 | 92,765 |
Rowland Charles A Jr | Director | 09/14/2022 | 29,652 |
Rowland Charles A Jr | Director | 09/13/2022 | 97,752 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 07/15/2022 | 101,597 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/15/2022 | 31,355 |
Norkunas Matthew | CHIEF FINANCIAL OFFICER | 07/15/2022 | 31,355 |
Paone Antoinette | CHIEF OPERATING OFFICER | 07/15/2022 | 17,390 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/15/2022 | 31,355 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 07/15/2022 | 31,355 |
Nicholson Donald William | Director | 03/09/2022 | 10,983 |
Nicholson Donald William | Director | 03/10/2022 | 38,273 |
Rhodes Jason P | Director | 09/29/2021 | 407,850 |
Rhodes Jason P | Director | 09/28/2021 | 330,972 |
Rhodes Jason P | Director | 09/27/2021 | 1,320,697 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/28/2021 | 606 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/28/2021 | 330,366 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/27/2021 | 2,442 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/27/2021 | 1,318,256 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/29/2021 | 738 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/29/2021 | 407,112 |
Rhodes Jason P | Director | 09/22/2021 | 792,705 |
Rhodes Jason P | Director | 09/24/2021 | 747,161 |
Rhodes Jason P | Director | 09/23/2021 | 1,972,127 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/24/2021 | 1,395 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/23/2021 | 3,659 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/22/2021 | 1,476 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/24/2021 | 745,765 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/23/2021 | 1,968,469 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 09/22/2021 | 791,229 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/14/2021 | 20,655 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/14/2021 | 126,315 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/10/2021 | 13,770 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 09/10/2021 | 77,910 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/23/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/23/2021 | 37,560 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/10/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 08/10/2021 | 33,943 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/12/2021 | 13,770 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 07/12/2021 | 75,087 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/08/2021 | 18,153 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 07/08/2021 | 88,670 |
Rhodes Jason P | Director | 06/24/2021 | 801,618 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/24/2021 | 800,119 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/24/2021 | 1,500 |
Rhodes Jason P | Director | 06/23/2021 | 1,587,548 |
Rhodes Jason P | Director | 06/22/2021 | 1,461,479 |
Rhodes Jason P | Director | 06/21/2021 | 1,586,940 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/23/2021 | 1,584,606 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/21/2021 | 1,584,009 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/22/2021 | 2,695 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/22/2021 | 1,458,784 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/23/2021 | 2,942 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 06/21/2021 | 2,931 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 05/27/2021 | 6,885 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 05/27/2021 | 51,075 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/22/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 04/22/2021 | 83,300 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/21/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/22/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/22/2021 | 51,045 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/21/2021 | 46,605 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/16/2021 | 900 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 04/16/2021 | 42,045 |
Rhodes Jason P | Director | 04/14/2021 | 622,995 |
Rhodes Jason P | Director | 04/13/2021 | 1,085,744 |
Rhodes Jason P | Director | 04/12/2021 | 1,938,229 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/13/2021 | 1,085,744 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/12/2021 | 1,938,229 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/14/2021 | 622,995 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/09/2021 | 1,205,948 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/08/2021 | 1,241,241 |
ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | 04/07/2021 | 1,136,671 |
Rhodes Jason P | Director | 04/07/2021 | 1,136,671 |
Rhodes Jason P | Director | 04/09/2021 | 1,205,948 |
Rhodes Jason P | Director | 04/08/2021 | 1,241,241 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 03/10/2021 | 6,300 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 03/10/2021 | 367,209 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 03/05/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 03/05/2021 | 354,267 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/03/2021 | 13,770 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/03/2021 | 124,140 |
MCDONOUGH GEOFF | PRESIDENT AND CEO | 03/01/2021 | 375,801 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/01/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 03/01/2021 | 97,099 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 02/10/2021 | 6,240 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 02/10/2021 | 359,856 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 02/08/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 02/08/2021 | 375,954 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 02/02/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 02/02/2021 | 82,625 |
Angelino Mark D. | CHIEF OPERATING OFFICER | 01/15/2021 | 34,425 |
Angelino Mark D. | CHIEF OPERATING OFFICER | 01/15/2021 | 247,273 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/14/2021 | 11,475 |
Zimmermann Tracy | CHIEF DEVELOPMENT OFFICER | 01/14/2021 | 82,725 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/14/2021 | 3,378 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/14/2021 | 183,212 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/11/2021 | 51,716 |
Kerr Douglas | CHIEF MEDICAL OFFICER | 01/11/2021 | 310,768 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/11/2021 | 8,892 |
Stanton Matthew | CHIEF SCIENTIFIC OFFICER | 01/11/2021 | 410,372 |
Nicholson Donald William | Director | 01/11/2021 | 99,985 |
Rowland Charles A Jr | Director | 01/11/2021 | 499,996 |
Angelino Mark D. | Chief Operating Officer | 12/15/2020 | 24,332 |
Angelino Mark D. | Chief Operating Officer | 12/15/2020 | 185,431 |
Stanton Matthew | Chief Scientific Officer | 12/10/2020 | 6,324 |
Stanton Matthew | Chief Scientific Officer | 12/10/2020 | 396,499 |
Angelino Mark D. | Chief Operating Officer | 08/14/2020 | 37,536 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 06/16/2020 | 20,900,000 |
Invus Public Equities, L.P. | 10% Owner | 06/16/2020 | 15,200,000 |
Rowland Charles A Jr | Director | 06/16/2020 | 570,000 |
Casdin Capital, LLC | 10% Owner | 06/16/2020 | 12,350,000 |
Zone Healthcare Holdings, LLC | 10% Owner | 06/16/2020 | 7,600,000 |
Seybold William | 10% Owner | 06/16/2020 | 7,600,000 |
Flynn James E | 10% Owner | 06/16/2020 | 4,275,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,168,415 | 0.00013% | -5.53% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,077,963 | 0.00019% | 6.54% | Other |
RENAISSANCE TECHNOLOGIES LLC | 689,400 | 0.00176% | 119% | Other |
D. E. SHAW & CO., INC. | 283,108 | 0.00041% | 1033.07% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View